Using indirect comparisons in pharmacoeconomic examination

by Yu. E. Balykina, A. S. Kolbin
Published 2015-03-01

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia

by I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina
Published 2018-05-01

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia

by I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina
Published 2018-08-01

Modeling microbial drug-resistance: from mathematics to pharmacoeconomics

by Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko
Published 2018-05-01

Pharmacoeconomic evaluation of mirabegron: results of the healthcare budget impact analysis

by A. S. Kolbin, I. A. Vilium, M. A. Proskurin, Yu. E. Balykina
Published 2018-06-01

Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases

by A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina
Published 2018-05-01

Pharmacoeconomic analysis of botulinum toxin in complex therapy for cerebral palsy

by A. S. Kolbin, I. A. Vilum, M. A. Proskurin, Yu. E. Balykina
Published 2018-06-01

Pharmacoeconomic analysis of the use of botulinum toxin in the treatment of poststroke spasticity

by A. S. Kolbin, I. A. Vilum, M. A. Proskurin, Yu. E. Balykina
Published 2018-05-01

PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD

by A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin
Published 2015-03-01

Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention...

by A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
Published 2015-03-01

Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation

by A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin
Published 2018-05-01

Pharmacoeconomic analysis of Flemoclav Solutab® use in adult patients with acute sinusitis in routine outpatient clinical practice in Russia

by A. S. Kolbin, I. A. Vilum, M. A. Proskurin, Yu. E. Balykina
Published 2018-05-01

Pharmacoeconomic analysis of the use of ibrutinib in therapy of the first line of a chronic lymphocytic leukaemia for patients with 17p deletion

by A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin
Published 2018-05-01

Pharmacoeconomic analysis of trastuzumab emtanzine comparing to lapatinib + capecitabine in pa...

by A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, D. R. Naskhletashvili
Published 2018-05-01

BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD

by A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
Published 2015-06-01

Economic analysis of Lixisenatide in Diabetes Mellitus Type 2

by A. S. Kolbin, A. A. Mosikyan, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, W. Zhao
Published 2018-05-01

Health technology assessment of hyaluronans in osteoarthritis treatment

by A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin
Published 2018-06-01

PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC...

by A. S. Kolbin, I. A. Vilum, М. A. Proskurin, Yu. E. Balykina
Published 2017-05-01

PROBLEMS OF COMPLICATED INTRA-ABDOMINAL INFECTION’S ANTIBACTERIAL TREATMENT IN MULTIDISCIPLINARY HOSPITALS

by Yu. M. Gomon, A. S. Kolbin, Yu. E. Balykina, M. A. Arepyeva, S. V. Sidorenko, V. V. Strizheletskiy, I. G. Ivanov, Yu. V. Lobzin, О. A. Grinenko
Published 2017-12-01

Health technology assessment of colorectal cancer chemotherapy with afl ibercept

by A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin
Published 2018-05-01